Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Calcium and Magnesium for Prevention of Ixabepilone Induced Peripheral Neuropathy: A Phase III Double-Blind Placebo Controlled Study

NCT00998738 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00998738
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00998738 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Calcium and Magnesium for Prevention of Ixabepilone Induced Peripheral Neuropathy: A Phase III Double-Blind Placebo Controlled Study
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 2009
Completion date
January 31, 2013
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuropathy, pain, recurrent breast carcinoma, stage iv breast cancer